KING KHALID NATIONAL GUARD HOSPITAL

PHARMACY AND THERAPEUTICS COMMITTEE

DRUG EVALUATION
GENERIC NAME OF THE DRUG: MEBO OINTMENT
Requestor:
Dr. Mansoor Ahmed Khan.
Clinical Pharmacist Adult Oncology / Hematology.
Manufacturer:
Julphar.
1.

Trade Name:

-sitosterol.
2.

AHFS Pharmacology- Therapeutic Class:

Tissue healing agent:
1. Skin Regeneration.
2. Analgesic Effects.
3. Prevention and Control of Infection ( Antibiotic ).
4. Anti-inflammatory Effects.

3.

Related Agents Already on Formulary:

Flamazine ( Silver Sulfadiazine )

4.

FDA Approved Indications:

1. First-degree burns, where the pain relief and the fast healing are remarkable, e.g.
sunburn.
2. Second degree burns, superficial and deep. If properly applied, no skin grafting is
needed and regeneration takes place from hair follicles and glands in the dermis
and subcutaneous tissue.
3. Third degree burns, to isolate the wound, reduce pain, and expedite nonsurgical
debridement of the necrotic tissue to prepare the wound for grafting.

5.

Registered in the Kingdom:

6.

Rationale for Formulary Addition:

6.1

Physicians (Requestors) perspective

6.2

Objective Literature Evaluation:

Yes

No